- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Covid-19: Brazil enters agreement with UK to produce Oxford-AstraZeneca vaccine
"If the efficacy is demonstrated, we will have 100 million doses for the Brazilian population," the ministry said in a statement, explaining that it had accepted a proposal from the laboratory and the British embassy in Brazil to cooperate in the technological development of the so-called ChAdOx1 vaccine, Xinhua reported.
Sao Paulo: The Brazilian Ministry of Health announced on Saturday an agreement with the UK to acquire technology to locally produce a vaccine against Covid-19 that is currently being developed by the University of Oxford and British pharmaceutical company AstraZeneca.
"If the efficacy is demonstrated, we will have 100 million doses for the Brazilian population," the ministry said in a statement, explaining that it had accepted a proposal from the laboratory and the British embassy in Brazil to cooperate in the technological development of the so-called ChAdOx1 vaccine, Xinhua reported.
At a press conference, the Secretary of Health Surveillance Arnaldo Correia de Medeiros explained that the Oswaldo Cruz Foundation (Fiocruz) will manufacture the vaccine using foreign technology.
If testing shows the vaccine is effective, Brazil will initially receive 30.4 million doses in two batches: 15.2 million in December 2020 and the rest in January 2021, with a value of about $127 million.
The Ministry of Health said that it will buy another 70 million doses, for a total of 100 million, at an estimated price of $2.30 per dose.
The vaccine project is currently in phase 3 of development, the last phase before approval and distribution, and testing began this week with the participation of Brazilian volunteers in a study carried out by the Federal University of Sao Paulo.
On Friday, the World Health Organization stated that this is the vaccine that is at the most advanced stage of development.
Brazil has so far reported over 55,000 deaths from the novel coronavirus and more than 1.2 million cases.
Read also: World May Have Covid-19 Vaccine In A Year, UK Pharma Company Leading In Race: WHO
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751